Atrial Natriuretic Factor: Clinical Trials

4 trials of Atrial Natriuretic Factor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 not yet recruiting. 2 Phase 2, 1 Not applicable, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Not applicable1Not yet recruiting 1
Phase 11Completed 1
Phase 31Completed 1

Follow Atrial Natriuretic Factor: new trials by email Literature Review of Atrial Natriuretic Factor trials Research Report on Atrial Natriuretic Factor

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Management of Epistaxis Comparing Nasal Packing Versus Greater Palatine Foramen Block
Greater Palatine Foramen Block with 2% xylocaine with adrenaline, Anterior Nasal Packing - Epistaxis Nosebleed, Greater Palatine Foramen
Not applicableNot yet recruitingSheikh Zayed Federal Postgraduate Medical Institute402026-03-012026-02-24
Prevention of Akute Kidney Injury, Hearttransplant, ANP
ANP, Placebo - Acute Kidney Injury
Phase 3CompletedSahlgrenska University Hospital862016-09-252022-02-09
Family Training Program for Parents of Substance Using Adolescents
Community Reinforcement and Family Training, Al-Anon Facilitation - Substance-Related Disorders, Drug Addiction
Phase 1 / Phase 2CompletedTreatment Research Institute1262011-01-012023-03-28
Prevention Of Nephrotoxicity Following Bone Marrow Transplantation Using Urodilatin and Mannitol
URODILATIN (ULARITIDE, ATRIAL NATRIURETIC PEPTIDE), MANNITOL - Renal Dysfunction, Acute Renal Failure
Phase 2CompletedRocky Mountain Cancer Centers202003-07-012008-06-03

Conditions studied

Acute Kidney Injury (2)  ·  Behavior, Addictive (1)  ·  Epistaxis (1)  ·  Renal Insufficiency (1)  ·  Substance-Related Disorders (1)

Sponsors

Rocky Mountain Cancer Centers (1)  ·  Sahlgrenska University Hospital (1)  ·  Sheikh Zayed Federal Postgraduate Medical Institute (1)  ·  Treatment Research Institute (1)

Countries

United States (2)  ·  Sweden (1)

Top investigators

Chirag R Parikh, MD, PhD (1)  ·  Kimberly C Kirby, PhD (1)  ·  Sven-Erik Ricksten, Prof (1)

Results publications

PMID 39878152

NIH funding

P50DA027841 (1)